Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
- Status
- TERMINATED
- Phase
- PHASE1
Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels
- Status
- COMPLETED
- Phase
- PHASE2
Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study
- Status
- COMPLETED
- Phase
- PHASE2
Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis
- Status
- COMPLETED
- Phase
- PHASE2
Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE2
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)
- Status
- COMPLETED
- Phase
- PHASE3
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3